Join
Live feed
·
PRReleasevia Quantisnow
CinCor Pharma Inc. logo

CinCor Pharma Announces Late-Breaking Presentation of Phase 2 BrigHtn Data on Baxdrostat in Treatment-Resistant Hypertension at the 2022 American Heart Association Scientific Sessions

ByQuantisnow·Wall Street's wire, on your screen.
CINC· CinCor Pharma Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CINC (CinCor Pharma Inc.) and more on Quantisnow.